SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

Traders are discussing a sharp collapse in the token's value following its launch, with many characterizing the rapid decline as a rug pull. While some express frustration over significant financial losses, others are debating the speculative nature of political-themed meme coins.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF is trending as traders speculate on the impact of ongoing geopolitical instability and shipping disruptions in the Strait of Hormuz on global tanker freight rates. Community sentiment is largely bullish, driven by the view that continued conflicts will keep tanker demand and freight costs elevated, though some traders express caution regarding the asset's extreme volatility and long-term sustainability.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as traders debate the company's Q2 performance, specifically focusing on Vevye revenue, gross-to-net dynamics, and the impact of recent institutional stake accumulation. The discussion highlights a divide between long-term optimism regarding the retina portfolio and concerns over management's ability to consistently meet quarterly guidance.

OpenAI

OpenAI is trending as the community debates its upcoming IPO timing and ongoing leadership turnover, while also discussing the broader AI industry's push to balance innovation with safety concerns. Traders remain focused on the company's high capital expenditures and intense competition with other AI labs like Anthropic.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canada is trending as traders discuss the airline's resilience, booking demand, and capacity adjustments in response to elevated jet fuel costs and ongoing geopolitical tensions affecting global air travel. The conversation is largely split between bullish participants who point to strong load factors and yield management, and bears who express concerns about the long-term impact of high fuel prices and broader economic risks.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is facing downward pressure following the release of Phase 3 clinical data for its psoriasis treatment, which failed to demonstrate clear superiority over existing therapies despite meeting primary endpoints. Investors are expressing frustration with management's perceived lack of communication and transparency regarding the results, leading to debates over whether the company should prioritize a buyout or proceed with its strategy of independent commercialization.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is trending as the stock breaks out to new all-time highs, driven by investor optimism over its role in the AI infrastructure buildout and strong demand for high-speed data center networking. While sentiment is overwhelmingly bullish, some traders are expressing caution regarding current valuation levels and the potential for a pullback following the recent rally.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech shares are experiencing volatility as investors react to the company's recent Q2 earnings report, which included downward revisions to revenue guidance and a net loss. Sentiment is further clouded by the upcoming departure of its co-founders by the end of 2026 to launch a separate mRNA venture, with traders debating whether this transition reflects a strategic refocusing or operational instability.

Endeavour Silver Corp. is a mineral company, which engages in the evaluation, acquisition, development and exploitation of precious metal properties in Mexico and Chile. The firm's projects include the Terronera property in Jalisco, the El Compas property, the Guanacevi Mine in Durango, Bolanitos Mines in Guanajuato, and the Parral project in Chihuahua, Mexico. The company was founded by Bradford James Cooke on March 11, 1981 and is headquartered in Vancouver, Canada.

Endeavour Silver Corp.

Endeavour Silver is trending due to community discussions surrounding its silver production growth and the resumption of operations at the Terronera mine following a brief blockade. Traders are also actively debating the broader silver equities market, fueled by speculative sentiment about rising silver prices and the historical performance of mining stocks during commodity bull cycles.

Anthropic

Anthropic is trending due to the announcement of a massive computing deal with Nscale to support its AI infrastructure ahead of a highly anticipated mega-IPO. The company continues to generate significant debate regarding its valuation, the pace of AI development, and the risks associated with frontier AI models.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NMM Q2 &#39;26 Earnings Results &amp; Recap

Navios Maritime Partners L.P. reported Q2 2026 revenue of $410.2 million and net income of $167.9 million, with earnings per common unit of $5.78 and Adjusted EBITDA of $242.2 million.

msk vl

Stocktwits

Navios Maritime Partners L.P.

 Q2 '26 Earnings Results & Recap

Navios Maritime Partners L.P. reported Q2 2026 revenue of $410.2 million and net income of $167.9 million, with earnings per common unit of $5.78 and Adjusted EBITDA of $242.2 million.

This account has been verified as an official STOCKTWITS representative.